33
/ru/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
2150408
176282
2
Create a timeline
Public Timelines
For educational institutions For teachers For students Cabinet
For educational institutions For teachers For students Open cabinet
FAQ Получить премиум
Create a timeline
Public timelines
FAQ
About & FeedbackСоглашениеПриватностьFAQ
Support 24/7  
CabinetGet premium
Donate

23 фев 2012 г. - Ado-Trastuzumab Emtansine (T-DM1) Approved

Описание:

FDA approves Ado-Trastuzumab Emtansine (T-DM1) for the treatment of patients with metastatic HER2-positive breast cancer. HER2 makes up 20% of all cases for breast cancer.

Добавлено на ленту времени:

Cancer Timeline

ByGabriel Tackett
15 ноя 2018
0
0
354

Дата:

23 фев 2012 г.
Сейчас
~ 13 г назад
About & FeedbackСоглашениеПриватностьFAQ
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL